GL1X · GenesisL1 explorer

MolNFT v1 · #37314 · protein

X-ray crystal structure of HIV-1 protease crm mutant complexed with atazanavir (bms-232632)

2FXE · Pol protein: “X-ray crystal structure of HIV-1 protease crm mutant complexed with atazanavir (bms-232632)”. X-ray diffraction, 2 ligands (DR7, SO4), 1 pocket (best druggability 0.72). MolNFT v1 #37314 on GenesisL1: 3D structure…

PDB
2FXE
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pol protein
EC
3.4.23.16
Ligands
DR7, SO4
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPol protein (EC 3.4.23.16)protein994% helix, 56% strand—

Ligands and binding sites

  • DR7 · (3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5, 6,10,13-pentaazatetradecanedioic acid dimethyl ester · ligand · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14180.720.8244DR7

Interfaces

1 interface between chains.

  • A–B · 1835 Ų buried · 39 hydrogen bonds · protein-protein

Compared structures

  • 2FXE · X-ray crystal structure of HIV-1 protease CRM mutant complexed with atazanavir… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.